Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for MNKD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2002. Start Trial.
Date Value
June 30, 2026 -0.924M
March 31, 2026 -0.27M
December 31, 2025 1.338M
September 30, 2025 -0.05M
June 30, 2025 -1.288M
March 31, 2025 0.00
December 31, 2024 2.32M
September 30, 2024 0.00
June 30, 2024 -0.959M
March 31, 2024 -1.361M
December 31, 2023 0.00
September 30, 2023 -4.038M
June 30, 2023 -1.515M
March 31, 2023 -1.226M
December 31, 2022 -2.903M
September 30, 2022 -19.22M
June 30, 2022 0.377M
March 31, 2022 -0.813M
December 31, 2021 3.082M
September 30, 2021 0.00
June 30, 2021 -0.106M
March 31, 2021 -1.848M
December 31, 2020 -8.362M
September 30, 2020 -2.538M
June 30, 2020 -23.19M
Date Value
March 31, 2020 -0.656M
December 31, 2019 -7.118M
September 30, 2019 -0.218M
June 30, 2019 -1.827M
March 31, 2019 0.00
December 31, 2018 -38.35M
September 30, 2018 -0.177M
June 30, 2018 -26.72M
March 31, 2018 -0.609M
December 31, 2017 -58.25M
September 30, 2017 0.00
June 30, 2017 0.00
March 31, 2017 0.00
December 31, 2016 -0.282M
September 30, 2016 -49.86M
June 30, 2016 2.411M
March 31, 2016 -0.467M
December 31, 2015 -49.03M
September 30, 2015 -12.92M
June 30, 2015 -8.702M
March 31, 2015 -6.168M
December 31, 2014 -1.547M
September 30, 2014 -17.95M
June 30, 2014 -17.22M
March 31, 2014 -3.401M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
United Therapeutics Corp. -126.30M
ACADIA Pharmaceuticals, Inc. -10.49M
Gilead Sciences, Inc. 346.00M
Vertex Pharmaceuticals, Inc. 421.80M
Ocugen, Inc. -0.587M